1 About Wegovy (semaglutide 2.4 mg) Wegovy (once-weekly subcutaneous semaglutide 2.4 mg) is a GLP-1 receptor agonist indicated as an adjunct to a reduced calorie diet and increased physical activity for chronic weight management in adults with a BMI of 30 kg/m 2 or greater (obesity), adults with a BMI of 27 kg/m 2 or greater (overweight) in the presence of at least one weight-related comorbid condition, and paediatric patients aged 12 years and older with an initial BMI at the 95th percentile or greater for age and gender (obesity) 8
Firstly, its available as an oral pill, meaning no nasty needles, and secondly, this compound doesnt act on hunger levels
Nielsen R, Jorsal A, Iversen P, Tolbod LP, Bouchelouche K, Srensen J, Harms HJ, Flyvbjerg A, Tarnow L, Kistorp C, et al
J Mol Neurosci (2002) 18:714
It does not require pen needles, syringes, sharps disposal, or injection-site rotation
project, Bruce Merrifield asked me to find a subject Id be excited to work on for years